TMED9

Transmembrane emp24 domain-containing protein 9 · Q9BVK6 · TMED9 on Sugi Atlas →

0 patent compounds predicted against TMED9, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TMED9 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101) PHASE1/PHASE2COMPLETED
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma PHASE2RECRUITING
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma PHASE2UNKNOWN
Evaluation of Serum Tumor Endothelial Marker1 as a Potential Biomarker for Colorectal Cancer Diagnosis and Cancer Progression nanNOT_YET_RECRUITING
Immunophenotypic Evaluation of CD305 and CD85d in B-Cell Lymphoid Neoplasms nanNOT_YET_RECRUITING
Evaluation of CEMIP in Pancreatic Cancer nanUNKNOWN
Evaluation of Serum Gasdermin D Level As a Potential Biomarker of Disease Activity in Vitiligo Patients nanUNKNOWN
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Mitigating Mitochondrial RNA Release During Aging to Control Inflammation and Senescence nanNOT_YET_RECRUITING
Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples. nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients nanRECRUITING
Genome Environment Microbiome and Metabolome in Autism Study nanCOMPLETED
Study of the Genetic Factors Involved in Autism and Related Disorders nanRECRUITING
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Purinergic Signaling and the Postmenopausal Heart nanRECRUITING
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
The Role of Programmed Death Ligand -1 (Pdl-1) in Lung Cancer nanCOMPLETED
Genetic Analyses of Nonsyndromic and Syndromic Deafness in Pakistan nanENROLLING_BY_INVITATION
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia nanRECRUITING
Genetics of Middle Ear Disease nanCOMPLETED
Identification of New Diagnostic Protein Markers for Colorectal Cancer nanCOMPLETED
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma nanCOMPLETED
Transcriptomic Profile of Patients Treated With Different Modalities of Spinal Cord Stimulation nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a TMED9 binder may also engage these)

ProteinNameSimilarity
Q3T133 1.000 Q3T133 →
Q99KF1 1.000 Q99KF1 →
O35587 1.000 O35587 →
Q63584 1.000 Q63584 →
Q8R1V4 1.000 Q8R1V4 →
Q5RE32 1.000 Q5RE32 →
TMED10 Transmembrane emp24 domain-containing protein 10 1.000 landscape →
Q5E971 1.000 Q5E971 →
B3MTS8 1.000 B3MTS8 →
P27869 1.000 P27869 →
B4GMC3 1.000 B4GMC3 →
B4KB41 1.000 B4KB41 →
Q28735 1.000 Q28735 →
Q5I0E7 0.999 Q5I0E7 →
B4PVC6 0.999 B4PVC6 →
B4K4G5 0.999 B4K4G5 →
B3LVB0 0.999 B3LVB0 →
Q295B2 0.999 Q295B2 →
Q7Z7H5 0.998 Q7Z7H5 →
Q9I7K5 0.998 Q9I7K5 →
B4HJV5 0.997 B4HJV5 →
Q8SXY6 0.997 Q8SXY6 →
B4JYU5 0.997 B4JYU5 →
Q4P958 0.997 Q4P958 →
B3P6T8 0.997 B3P6T8 →
B4PUZ3 0.997 B4PUZ3 →
Q8VY92 0.996 Q8VY92 →
Q9LQY3 0.996 Q9LQY3 →
Q9D1D4 0.996 Q9D1D4 →
Q6C503 0.996 Q6C503 →